Perspectives
Facing the tidal wave
De-risking pharma and creating value for patients
The pharmaceutical industry is facing a ‘tidal wave’ of complex age and behaviour-related diseases creating increased economic, scientific and delivery risks. How can pharma companies evolve to overcome these obstacles?